The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
its time to leave Uksmouth, take the technology to China, there are over 1000 coal plants in China, if the Welsh are too stupid to see the potential of burning waste plastic for electricity then give it to the Chinese
massive overreaction, watch everyone pile in tomorrow, note COMFORTABLY
'Polarean's net cash balance of $38.2m as of 30 June 2021 allows the Company to fund operations comfortably through the anticipated Company response and FDA review periods'
Polarean will work to address the issues identified by the FDA with a view to resubmitting the NDA and securing FDA approval as quickly as possible. Following resubmission of the NDA, it is expected that the FDA review period will take 2-6 months.
https://angrafx.com/
professional looking website
all the recent director buys were at 2p, Bai paid £900k and Teo £500k, they have plenty of skin in the game
24-Mar-21 23-Mar-21 Buy Raphael Chiah Chiu Teo 2.00 GBX 25,000,000 207,603,260
24-Mar-21 23-Mar-21 Buy Tan Guan Han, Shayne 2.00 GBX 5,000,000 5,000,000
24-Mar-21 23-Mar-21 Buy Bai GuoJin 2.00 GBX 45,000,000 124,200,000
GSTechnologies Limited (LSE: GST), the integrated information and communication technology infrastructure solutions provider, is pleased to announce that the Company has entered into a conditional agreement to acquire the whole of the issued share capital of Angra Limited ("Angra"), a UK-based foreign exchange and payment services company (the "Acquisition").
Angra, which operates under the AngraFX brand name, is a Financial Conduct Authority ("FCA") approved Authorised Payment Institution ("API"), conducting fast, secure and low-cost foreign exchange business and payment services internationally. In the year ended 30 September 2020 Angra transacted business to the value of £64.0 million.
its a supply agreement which definitely counts as price sensitive news!
Vatic Health Limited, a UK based health-tech company, has today signed the supply agreement with one of the largest manufacturers of lateral flow tests in Europe, Abingdon Health.